Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
https://www.sakaltimes.com/pune/covid-19-pune-critical-patients-get-army-hospital%E2%80%99s-attention-55830
Traumakine is one drug of solidarity trial in India.
https://www.gate5.co.za/read/59986/qv/87087356/17185168/144573/p
"...Faron is participating in a WHO study looking for treatments against the coronavirus. According to Jalkanen, research results can be done in less than half a year.
Time in terms of how many patients can be recruited. Research is being conducted in South America and India.."
https://www.kauppalehti.fi/uutiset/koronalaakkeen-kehittajissa-taas-uusi-kurssiraketti-laake-perustuu-samaan-aineeseen-kuin-suomalaisen-faronin-traumakine/72870e04-2f3c-4aa5-a585-c104aa444a4e
Kari Tikkinen on twitter 17.5.2020 : Thanks for asking! The intention is that Traumakine has its own branch. In terms of results, I can find the best one next Wednesday after the WHO #SOLIDARITYResearch: International Steering Committee meeting. Do you remember if I forget them? https://twitter.com/KariTikkinen/status/1261955252884049922?s=19
traumakine is possibly in its own branch of research? when who talks about interferon beta-1a, do they mean faron's traumakine?
Does anyone know of any other company involved in the solidaritytrial in the Interferon branch?
https://www.bloomberg.com/amp/news/articles/2020-07-10/gilead-s-remdesivir-linked-to-62-reduction-in-mortality-risk
->gilead's stock +2.25%
(Market cap ~96B)
positive news about traumakine -> Farn -> ?
(Market cap ~ 138 million)
Wait and hold.
https://3wnews.org/uncategorised/2277553/acute-lung-injury-market-promising-growth-opportunities-and-forecast-2017-2025/
"..Adenosine is also blamable for enhancing the endothelial barrier over the activation of adenosine receptor. Faron Pharmaceuticals, Ltd. is at present engaged in the development of pharmacological treatments for acute lung injury with the help of a consortium consisting European Commission, Traumakine program (University College London Hospital (UCLH) and University of Torino and University of Turku). The FP-1201-lyo treatment for acute lung injury is now in the 3rd phase of clinical trials and is anticipated to obtain European marketing authorization in the near future.."
"Merck has been asked by the European Commission to be prepared to supply one of its medicines, Rebif (Interferon beta-1a), to EU countries upon request if and when the indication for COVID-19 treatment is adjudicated," the company said in a statement to Reuters.
https://uk.finance.yahoo.com/news/merck-says-agreed-supply-potential-152818469.html
https://www.minuto30.com/nacional/clinicas-ensayo-colombia/1077758/
https://www.indiatoday.in/amp/world/story/who-sees-first-results-from-coronavirus-drug-trials-within-two-weeks-1696848-2020-07-04
The data of WHO's solidarity trial will be coming.
https://twitter.com/arabnews/status/1279071776295829507?s=19
COVID-19 drug repurposing research: https://en.wikipedia.org/wiki/COVID-19_drug_repurposing_research